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ABSTRACT
The transcription factor MEF2C (Myocyte Enhancer Factor 2C) plays an established role in the
early steps of myogenic differentiation. However, the involvement of MEF2C in adult myogene-
sis and in muscle regeneration has not yet been systematically investigated. Alternative splicing
of mammalian MEF2C transcripts gives rise to two mutually exclusive protein variants: MEF2Ca2
which exerts a positive control of myogenic differentiation, and MEF2Ca1, in which the a1
domain acts as trans-repressor of the MEF2C pro-differentiation activity itself. However,
MEF2Ca1 variants are persistently expressed in differentiating cultured myocytes, suggesting a
role in adult myogenesis. We found that overexpression of both MEF2Ca1/a2 proteins in a
mouse model of muscle injury promotes muscle regeneration and hypertrophy, with each iso-
form promoting different stages of myogenesis. Besides the ability of MEF2Ca2 to increase dif-
ferentiation, we found that overexpressed MEF2Ca1 enhances both proliferation and
differentiation of primary myoblasts, and activates the AKT/mTOR/S6K anabolic signaling path-
way in newly formed myoﬁbers. The multiple activities of MEF2Ca1 are modulated by phos-
phorylation of Ser98 and Ser110, two amino acid residues located in the a1 domain of
MEF2Ca1. These speciﬁc phosphorylations allow the interaction of MEF2Ca1 with the peptidyl-
prolyl isomerase PIN1, a regulator of MEF2C functions. Overall, in this study we established a
novel regulatory mechanism in which the expression and the phosphorylation of MEF2Ca1 are
critically required to sustain the adult myogenesis. The described molecular mechanism will rep-
resent a new potential target for the development of therapeutical strategies to treat muscle-
wasting diseases. STEM CELLS 2016; 00:000–000
SIGNIFICANCE STATEMENT
A deep understanding of the mechanisms that control adult muscle mass is crucial for develop-
ing strategies to counteract muscle wasting-associated disorders. Our work demonstrate that
MEF2C transcription factor promotes a balanced muscle growth by acting at two cellular levels:
by stimulating muscle differentiation of stem cell-derived muscle precursors and by activating
the protein synthesis pathway in differentiated myofibers. We show that the timely coordina-
tion of these activities is ensured by a molecular mechanism involving the cross-talk of alterna-
tive splicing and protein phosphorylation. Our findings supply evidence that modulating MEF2C
function might be a valuable therapeutic strategy for muscle wasting therapies.
INTRODUCTION
Skeletal muscle regeneration and hypertrophy
are key adaptive responses to both pathologi-
cal and physiological stimuli. Both processes
are sustained by a population of resident self-
renewing muscle stem cells, referred to as Sat-
ellite Cells (SC), located under the basal lamina
[1–4]. SC are quiescent in the adult steady
state, when triggered by signals resulting from
exercises or injuries, they become activated
and give rise to a population of myogenic pre-
cursor cells (myoblasts) that proliferate,
migrate and fuse with the host ﬁbers or gener-
ate new myoﬁbers leading to muscle growth/
repair. SC self-renewal also ensures the main-
tenance of a stem cell pool [5, 6]. During the
myogenic progression of SC, a controlled bal-
ance between proliferation, differentiation and
self-renewal is required, to assure efﬁcient
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muscle repair and maintenance throughout life. The transcrip-
tional control of these processes in vertebrates is mainly regu-
lated by a handful of protein families, including the paired
box transcription factors PAX3 and PAX7, the myogenic regula-
tory factors (MRFs), MYOD, MYOGENIN, MYF5, and MRF4, the
Myocyte Enhancer Factor-2 (MEF2) transcription factors and
the homeodomain transcription factors SIX [7–11]. In addition
to their roles in the transcriptional activation of muscle-
speciﬁc genes, these proteins are involved in controlling cell
cycle progression. Importantly, they are the ultimate targets
of multiple signaling pathways activated by external cues and,
by integrating these various signals, they determine the bal-
ance between muscle precursors proliferation and cell cycle
exit. There are four MEF2 proteins (MEF2A, -B, -C, and -D) in
vertebrates, their structures are tailored for receiving and
responding to multiple signaling pathways that control their
functions at several levels, including alternative splicing (AS)
of the encoding transcripts and post-translational modiﬁca-
tions [12–16]. It has been shown that skeletal muscle-speciﬁc
deletion of Mef2 genes results in impaired muscle regenera-
tion, however the involvement of MEF2 factors in the control
of muscle growth and regeneration has not yet been system-
atically investigated [7, 8]. It has been reported that mutually
exclusive AS of exons a1 and a2 in Mef2c and Mef2d tran-
scripts is regulated during skeletal myogenesis and that inclu-
sion of a2 exons in Mef2c and Mef2d transcripts is important
to guarantee efﬁcient myogenic differentiation in cultured
myoblasts and in vivo respectively, whereas the a1 domains
act as trans-repressors of MEF2 myogenic activity [15, 16].
However, the function associated with the a1 domains might
be more complex, as the a11 isoforms (MEF2Ca1 splice var-
iants) are persistently expressed in differentiating cultured
myocytes [15–17]. Likewise, we observed that inclusion of the
a1 exon in mouse Mef2c transcripts is upregulated in vivo in
the early phases of muscle regeneration and is maintained
during later stages of myogenesis, suggesting unexplored
functions for this isoform during adult myogenesis. In addition
to AS, covalent modiﬁcations such as phosphorylation, acety-
lation and sumoylation, are critical for modulating MEF2 func-
tion, however how these modiﬁcations are regulated during
myogenesis in vivo is still unknown [18–22]. Finally, the func-
tion of MEF2C is widely regulated by its direct physical inter-
action with several coactivators and corepressors [23]. For
instance, we had previously reported a regulatory mechanism
that represses MEF2-dependent transcription in muscle pre-
cursors via physical interaction with the peptidyl-prolyl cis-
trans isomerase PIN1 [24]. The PIN1/MEF2C interaction
requires phosphorylation of two serine residues, Ser98 and
Ser110, that are located in the a1 domain, raising the ques-
tion of how inclusion of the a1 exon in Mef2c transcripts,
phosphorylation of Ser98 and Ser110 in the encoded a1
domain and interaction with PIN1 are coordinated for the reg-
ulation of MEF2C function in adult myogenesis in vivo. In
order to elucidate the function of MEF2Ca1 in adult myogen-
esis, we have investigated the function of MEF2C protein var-
iants in SC using both in vitro and in vivo approaches. In
agreement with previous results [16], we observed that the
MEF2Ca2 isoform exhibits its myogenic activity also in vivo,
moreover, we provide the ﬁrst evidence of pro-hypertrophic
and pro-regenerative activities of MEF2Ca1 in skeletal muscle
mediated by multiple sequential mechanisms, including
stimulation of SC expansion and subsequent terminal differen-
tiation and activation of the PI3K/AKT-dependent protein syn-
thesis pathway in adult myoﬁbres. The switch between these
multiple mechanisms is associated with phosphorylation of
the Ser98 and Ser110 residues that regulates its interaction
with PIN1. We thus conclude that, the timely inclusion of a1
exon in Mef2c transcripts and phosphorylation of the corre-
sponding MEF2C isoform determines its protein interactions:
integration of these mechanisms leads to a coordinated mod-
ulation of MEF2C function during adult myogenesis.
MATERIALS AND METHODS
Cell Lines, Primary Cultures, and Single Myofibers
C2C12, COS1 and NIH 3T3 cells were maintained in DMEM/10%
FBS. To induce C2C12 cells differentiation, conﬂuent cells were
maintained in DMEM/2% Horse Serum (HS). Primary cultures of
SC were prepared from adult muscles of Pax3GFP/1 mice as
described [25] and grown in SC plating medium (40% F12/40%
DMEM/20% FBS, Ultroser). DMEM, F12 and FBS Gibco were
provided by Life Technologies, Thermoﬁsher, https://www.ther-
moﬁsher.com, FBS by Gibco, HS Hyclone by GE Healthcare,
http://www.gelifesciences.com, Ultroser Biosepra by Pall Corpo-
ration, http://www.pall.com. Adult (4 weeks old) C57BL6 mice
were killed by cervical dislocation, and the extensor digitorum
longus (EDL) muscles isolated and digested in collagenase as
described [26]. Myoﬁbres and associated SC were isolated and
cultured in suspension or in adhesion on matrigel-coated plates
(BD) in SC plating medium. To promote differentiation of prima-
ry SC-derived myoblasts, after 4-5 days of culture they were
kept in differentiation medium with low serum [27].
Muscle Regeneration
Mouse studies were performed in accordance with the cur-
rent version of the Italian Law on the Protection of Animals
and approved by the local ethics committee. Tibialis anterior
(TA) muscles of C57/BL6 mice (Charles River, http://www.
criver.com/) were chemically injured using cardiotoxin (CTX)
and after 2, 5 or 15 days of recovery, the injured and the con-
trolateral control muscles were collected and used for protein
and RNA extraction or embedded in OCT compound, frozen in
isopentane cooled with liquid nitrogen and then sectioned
(cross-section of 8 lm thickness) for immunoﬂuorescence
staining. To induce protein overexpression during muscle
regeneration, both TA muscles were injured and, after 48 h of
recovery, lentiviruses (multiplicity of infection-MOI-25) encod-
ing MEF2C isoforms were injected into one of the regenerat-
ing TA muscles, while the contralateral was injected with an
empty lentivirus. Muscle samples were collected at day 5 and
15 postinjury. Changes in distribution of ﬁber size was
assessed measuring the cross-sectional area (CSA) of myoﬁb-
ers. Counting was performed using NIH ImageJ and the distri-
bution of muscle-ﬁbers CSA was obtained by ranking the
ﬁbers by size and the mean6 SEM, the number of muscle
ﬁbers of n5 3 animals was calculated for each size range.
Immunofluorescence and Bimolecular Fluorescence
Complementation Assay
Isolated myoﬁbers, muscle sections or plated cells were ﬁxed
with 4% paraformaldehyde, permeabilized (0.2% Triton X-100,
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50 mM NH4Cl in PBS) and then blocked for 1 hour with 2%
HS, ﬁnally incubated overnight at 48C with primary antibodies.
Samples were stained with Hoechst (Sigma-Aldrich, Italy,
Milan http://www.sigmaaldrich.com) and secondary antibody
conjugated to a ﬂuorochrome. After immunostaining cover-
slips were mounted in Mowiol mounting medium and
observed under in a Zeiss Axioskop 40 ﬂuorescence micro-
scope equipped with an Axiocam HRC camera for image
acquisition. For the bimolecular ﬂuorescence complementa-
tion (BiFC) assay, isolated myoﬁbers cultured in adhesion
were transfected with the indicated plasmids using Lipofecta-
min LTX (Life Technologies), then treated as described [24].
Western Blot and Coimmunoprecipitation Assay
Western Blot assays were performed as described previously
[21]. When shown, the results were quantiﬁed by densitome-
try using ImageJ software. CoIP assays were performed as
described previously [24].
Transcription Reporter Assays
C2C12 and COS1 cells were cotransfected with pGL3(des-
MEF2)3, pRSVb-gal, and the MEF2C expression vectors, then
analyzed as described [24].
Antibodies. Mouse monoclonal antibodies were directed
against: PAX7 and MHC MF20 (Developmental Studies Hybrid-
oma Bank, IA, Iowa City, Iowa, http://dshb.biology.uiowa.edu/),
MYOD 5.8A (M3512 Dako, Milan, Italy, http://www.dako.com),
MYOGENIN F5D (M3559, Dako), DESMIN (D33 Dako), VINCULIN
(V4505 Sigma-Aldrich), DYSTROPHIN (ab 7164, Abcam, Milan,
Italy, http://www.abcam.com/), FLAG M2 (F3165, Sigma), AKT1
(2967, Cell Signaling, www.cellsignal.com).
Rabbit Monoclonal anti-MEF2C (D80C1, Cell Signaling). Rabbit
polyclonal antibodies were directed against: MYOD (C-20) (sc-
304, Santa Cruz, http://www.scbt.com/), MYOGENIN M-225
(sc-576 Santa Cruz), CAVEOLIN-1 (a gift from A. Fanzani, Bre-
scia), Ki67 (15580 Abcam), LAMININ (L9393 Sigma-Aldrich),
PIN1 (PC270, Calbiochem, http://www.abcam.com/), MEF2C
(SBS-002) (Sparrow Biosciences, http://sparrowbiosciences.
com/), HA (H6908; Sigma-Aldrich), RFP (1R10367 Life Technol-
ogies), mTOR (2972, Cell Signaling), pAKT (Thr308) (4056 Cell
Signaling), pAKT (Ser473) (9018 Cell Signaling), S6K (9202 Cell
Signaling), pS6K (Thr389) (9205 Cell Signaling), P38 (9212 Cell
Signaling). Anti-pSer98 MEF2C and anti-pSer110 MEF2C were
generated in rabbit using synthetic phosphorylated MEF2C
peptides.
Plasmids
pFLAG-MEF2Ca1 WT and 2SA are described in [21, 24],
pFLAG-MEF2Ca2 was a gift from Tod Gulick (Orlando). Lentivi-
ral vectors encoding MEF2Ca1 WT and 2SA were generated
by cloning the respective cDNAs in the pLENTI-CMV-RFP-2A-
PURO (Abm, www.abmgood.com). Vectors encoding for HA-
tagged PIN1 protein and the plasmids used for BIFC assay
were described in [24].
RNA Extraction and RT-PCR
Total RNA was extracted from muscles using TRIzol Plus RNA
Puriﬁcation System (Ambion, Milan, Italy, www.thermoﬁsher.com)
or from SC using total RNA puriﬁcation kit (Norgen Biotek, Thor-
old, ON, Canada, www.norgenbiotek.com). Reverse transcription
was performed using SuperScript III (Life Technologies, Milan, Ita-
ly, www.thermoﬁsher.com) and oligo dT (Life Technologies). The
cDNA was ampliﬁed by semiquantitative PCR or quantiﬁed in
qPCR. Primer sequences are available upon request. Real-Time
PCRs were performed using SYBR green reagent (ThermoFisher,
Milan, Italy, www.thermoﬁsher.com) in the LightCycler Roche PCR
machine.
Chromatin Immunoprecipitations
Chromatin immunoprecipitations were performed as previous-
ly described [21, 28, 29]. Five microgram of anti-MEF2 (C21
sc-313X, Santa Cruz) and anti-NFYB (GeneSpin, www.labome.
com) antibodies were added to each IP and incubated over-
night at 48C on a rotating wheel. DNAs were resuspended in
TE buffer and quantitative real-time PCR was performed using
SYBR green reagent (ThermoFisher) in the LightCycler Roche
PCR machine. The relative sample enrichment was calculated
with the following formula: 2DCtx22DCty, where DCt x5 Ct
input2 Ct sample and DCt y5 Ct input2 Ct control Ab. Data
have been shown as means of three independent
experiments.
RESULTS
Expression and Activity of MEF2Ca1 in Primary
Myoblasts
To elucidate the role played by the a1 domain of MEF2C in
primary myoblasts, we ﬁrst determined the dynamics of inclu-
sion of a1/a2 exons in Mef2c transcripts during the myogenic
progression of murine SC by semiquantitative PCR analysis.
For this purpose, we used exon-speciﬁc or common primers,
whose location is shown in Figure 1A and Supporting Informa-
tion Fig. 1A. Both strategies show that the a2 exon is ubiqui-
tously expressed in quiescent, proliferating and differentiated
SC-derived myoblasts. Inclusion of the a1 exon, almost unde-
tectable in quiescent SC, is enhanced in activated SC-derived
primary myoblasts, both a1 and a2 exons are highly
expressed in differentiating cells (Fig. 1A and Supporting Infor-
mation Fig. 1B). To monitor the dynamics of a exon at the
protein level, we cultured primary SC for 0, 48 and 72 hours
on ﬂoating myoﬁbers from EDL muscles and we performed
double immunolabeling for SC speciﬁc markers and MEF2C
using a generic anti-MEF2C and two a1 isoform-speciﬁc anti-
bodies developed and/or characterized in our laboratory (Sup-
porting Information Fig. 1C-G). We show that, although all
quiescent SC express MEF2C (n5 9 mice, >200 cells/mouse)
(Fig. 1B day 0), only MYOD positive-dividing and MYOGENIN
(MGN) positive-differentiating cells (Fig. 1C and 1D, days 2
and 3), express the a1 domain. We conﬁrmed that 97% of SC
on freshly isolated myoﬁbers were quiescent, CAVEOLIN-1
positive (Supporting Information Fig. 1H) [30]. Immunoblot
analysis conﬁrmed the presence of MEF2Ca1 protein in prolif-
erating and differentiated C2C12 cells (Supporting Information
Fig. 1I). Next, we tested the function of MEF2Ca1 in SC myo-
genic progression by overexpression. As Mef2c transcripts
have two additional alternatively spliced regions, b exon and
g domain [31–33] (Fig. 1A, left panel), we investigated their
expression in SC and found exclusive expression of the exon b
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skipped isoform, whereas both g1 and g- variants are equally
expressed (Supporting Information Fig. 1L). Therefore, we
decided to evaluate the activities of the a1 exon in a a11 b-
g1 context [24]. Freshly isolated SC were transduced with a
lentiviral vector carrying RFP and mouse MEF2Ca1 cDNAs and
their proliferation and differentiation potential were com-
pared to those of control cells (schematized in Supporting
Information Fig. 2A, >80% of RFP1 infected cells, Supporting
Information Fig. 2B). We observed a 38% increase in the
capacity of the cells to proliferate, upon overexpression of
Figure 1. MEF2Ca1 promotes SC proliferation and differentiation. (A): Left: structure of the coding exons of the mouse Mef2c tran-
script. Arrows show the primers annealing sites used to evaluate the expression of a1 and a2 exons. Right: expression levels of a exons
in quiescent (Q), proliferating (P) or differentiating (D) SC. Negative controls: 2RT, 2RNA, PCR reaction mix. Expression vectors of the
MEF2C isoforms were used as control templates. Rplp0 was used as a control of RNA quantities. Similar results were obtained from two
sets of samples. (B-D): Single myoﬁbers isolated from extensor digitorum longus muscles were cultured in ﬂoating conditions and immu-
nostained for MEF2C, PAX7, MYOD or MYOGENIN. MEF2C was detected with a general antibody (total) (B), or two isoform-speciﬁc anti-
bodies (MEF2Ca1* and MEF2Ca1) (C and D). Bars, 50 lm. (E, F): Primary SC were transduced with either control EV or MEF2Ca1
coding lentiviruses. 48 hours later, nuclei were stained with DAPI (E), 72 hours later cells were immunostained for MYOGENIN (F) and
counted. The number of control transduced cells was taken as one. Three independent experiments with duplicate samples were carried
out for each measurement. Error bars represent SEM. *, p< 0.05. Abbreviations: EV, empty vector; MEF2C, myocyte enhancer factor 2C
Rplp0, Ribosomal protein large P0; 2RT, nonreverse-transcribed RNA; 2RNA, reverse transcription mixture; SC, satellite cells.
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Figure 2. Dynamics of Ser98/110 Phosphorylation. (A): MEF2C protein structure and positioning of Ser98/110 residues. Sequences of the
mouse MEF2C a exons were aligned with ClustalW software, similar and identical residues are marked with dots and asterisks. Ser98/110
residues in a1 domain and the equivalent residues in a2 are marked in red. (B): Extracts were prepared from Mb or cells differentiated at
different times (Mt 0-24 hours) and immunoblotted for MHC, MEF2C, MEF2C phosphorylated on Ser98 and Ser110 (pSer98, pSer110). VIN-
CULIN was used as loading control. (C, D) Single myoﬁbers were immediately ﬁxed (Quiescence), cultured for 48 hours (Proliferation) (C) or
plated on gelatin-coated dishes and immunolocalized for pSer98/pSer110, and PAX7 or MYOD or MYOGENIN proteins at different times
after isolation. Bars, 50 lm (D). (E): C2C12 cells were transiently transfected with vectors encoding RFP and MEF2Ca1 wild type and mutat-
ed on Ser98/110 (2SA) or MEF2Ca2 vectors. RFP1 transfected cells were FACS-sorted, Plk2, JunB, and TnnC1 expression levels were ana-
lyzed by qPCR. Data are expressed as fold induction relative to control cells (EV). (F): Chromatin Immunoprecipitation analysis showing
MEF2 recruitment to the MRE in the regulatory region of Plk2 gene in C2C12 myoblasts. Values are represented as % of Input DNA6 s.e.
Statistical analysis (unpaired t test) was performed to compare the enrichment of MEF2 versus anti-FLAG control antibody. (G): Upper pan-
el: transactivation assays on C2C12 cells transfected with MEF2Ca1 or the 2SA mutant on a MEF2-dependent reporter. Luciferase activities
were normalized for transfection efﬁciency by using b-Galactosidase. Lower panel: Western blot analysis of the expression levels of ectopi-
cally expressed FLAG-tagged MEF2C proteins in transiently transfected C2C12 cells using an anti-FLAG antibody. Vinculin was used as load-
ing control. *, p< 0.05; **, p< 0.01. Abbreviations: Mb, myoblasts; MEF2C, myocyte enhancer factor 2C; MHC, myosin heavy chain.
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MEF2Ca1, as measured by cell number 48 hours postinfection
(Fig. 1E). The ability of MEF2Ca1 to promote cell proliferation
was also observed in nonmuscle cells such as NIH 3T3 mouse
ﬁbroblasts (Supporting Information Fig. 2C) and colon cancer
cells [17]. We used a similar approach to study the role of
MEF2Ca1 overexpression on terminal differentiation. For that
purpose, 3 days post-infection cells were ﬁxed and immunos-
tained for MYOGENIN. SC-derived myoblasts were kept sub-
conﬂuent and in growth medium, to dissect the effect of
MEF2C overexpression from that of density-dependent cell
cycle exit. In these conditions we observed a 25% increase of
MYOGENIN positive cells compared to controls (Fig. 1F), sug-
gesting that MEF2Ca1 up-regulation promotes differentiation
in addition to the pro-proliferative effect described above.
Phosphorylation of Ser98 and Ser110: A Regulatory
Switch
To gain insight into the molecular mechanisms responsible for
switching-on alternatively the pro-proliferative and the pro-
differentiative activities of MEF2Ca1, we focused our attention
on two phosphoacceptor sites, Ser98 and Ser110, located in a1
domain, whose phosphorylation regulates MEF2C function in
C2C12 myoblasts, allowing its association with PIN1, an inhibi-
tor of muscle terminal differentiation (Fig. 2A) [17, 24]. As a
ﬁrst step, we characterized the level of phosphorylation of
MEF2Ca1 during differentiation of C2C12 cells with phospho-
speciﬁc antibodies, that speciﬁcally recognize MEF2C phosphor-
ylated on Ser98 (anti-pSer98) or Ser110 (anti-pSer110) (Sup-
porting Information Fig. 2D). We found that Ser98/110 are
phosphorylated exclusively in myoblasts (Fig. 2B). Next, we per-
formed the same analysis in SC retained in their niche on iso-
lated myoﬁbers. Again we observed Ser98/110 phosphorylation
in proliferating MYOD1 primary myoblasts (Fig. 2C, prolifera-
tion). As concern differentiation, we plated single myoﬁbers on
Matrigel: Ser98 and Ser110 phosphorylation was detected in
MYOD1 proliferating SC-derived myoblasts (Fig. 2D, prolifera-
tion), but not in differentiating MYOGENIN1 cells (Fig. 2D, dif-
ferentiation). Overall our data indicate that MEF2Ca1
phosphorylation on Ser98/110 is restricted to proliferating myo-
blasts and absent in terminally differentiated cells. To test how
the phosphorylation of PIN1 binding sites in MEF2Ca1 could
affect proliferation and/or differentiation of SC, we investigated
its transcriptional potential in promoting the expression of dif-
ferent target genes: two immediate early genes, polo like
kinase 2 (Plk2) and JunB and troponin C1 (TnnC1), a myogenic
target. We found that MEF2Ca1 induced the expression of
both Plk2 and JunB endogenous genes and that this activation
depends on the presence of intact Ser98/110 phosphoacceptor
sites, given that equivalent levels (Supporting Information Fig.
2E) of the non-phosphorylatable 2SA mutant had no activity
(Fig. 2E). Conversely, the non-phosphorylatable 2SA mutant
stimulated the expression of TnnC1 more efﬁciently (32-fold)
than the pro-myogenic MEF2Ca2 isoform (28-fold) (Fig. 2E). In
order to investigate whether MEF2Ca1 directly regulates the
transcription of Plk2 and JunB genes, we looked at putative
MEF2 recognition elements (MREs) around their transcription
start sites by bioinformatics approach. We found putative MREs
in the regulatory regions of both genes (Supporting Information
Fig. 2F). Chromatin Immunoprecipitation (ChIP) experiments,
with chromatin from proliferating myoblasts, showed a signiﬁ-
cant enrichment of MEF2 binding over the control antibody in
the Plk2 amplicon containing the predicted MRE. The anti-NF-
YB antibody, which is able to recognize the CCAAT-binding fac-
tor NF-Y, was used as negative control antibody (Fig. 2F). Oppo-
sitely, a signiﬁcant percentage of input DNA was
immunoprecipitated by the anti-NF-YB antibody, but not by the
anti-MEF2, when qPCRs were performed with oligonucleotides
speciﬁc for the JunB CCAAT-regulatory region (Supporting Infor-
mation Fig. 2G). These results suggest a direct involvement of
MEF2Ca1 in regulating the transcription of Plk2 and an indirect
role in JunB regulation, possibly through the regulation of other
transcription factors. Overall our data indicate that phosphory-
lation of Ser98 and Ser110 inhibits the transcriptional potential
of MEF2Ca1 toward muscle-speciﬁc genes, while boosting the
activation, directly or indirectly, of cell-cycle related target
genes. Coherently, the 2SA mutant is more transcriptionally
active (two-fold) than the wild type MEF2Ca1 protein toward a
myogenic luciferase reporter gene in muscle (Fig. 2G) and non-
muscle cells (Supporting Information Fig. 2H). These ﬁndings
indicate a critical role for phosphorylation of Ser98 and Ser110
in a1-domain-mediated transcriptional activation of prolifera-
tion—versus differentiation—target genes, suggesting that this
covalent modiﬁcation is the molecular switch of the bi-modal
activity of MEF2C in SC.
PIN1/MEF2C Interaction in Primary Myoblasts
Next we determined the role of the peptidyl-prolyl cys/trans
isomerase PIN1 in modulating MEF2C function in SC. First, we
observed that Pin1 transcripts are upregulated in proliferating
SC-derived myoblasts by RT-PCR (Fig. 3A) and that all MYOD-
positive proliferating myoblasts express PIN1 by immunoﬂuo-
rescence on single myoﬁbers (Fig. 3B). To demonstrate that
the MEF2Ca1/PIN1 interaction takes place in adult myoblasts,
we used the BiFC approach [34]. To this end, MEF2Ca1 and
PIN1 were fused to the amino- or carboxyl-terminal fragment
of YFP, respectively, and transfected into SC-derived myo-
blasts, the fusion proteins Jun-YN and Fos-YC were used as
positive controls (Fig. 3C, panels ii, Fig. 3D, panels v). Coex-
pression of FLAG-tagged MEF2Ca1 and HA-tagged PIN1-YC in
plated SC resulted in complementation of the YFP in the
nucleus of MYOD positive proliferating SC (Fig. 3C, panels iii,
Fig. 3D, panels vi). Given that adult myoblasts also express
Mef2c transcripts including the a2 exon, we next investigated
whether PIN1 distinguishes between the two isoforms by
coimmunoprecipitation experiments in transfected COS cells.
As shown in Figure 3E, we found that only MEF2Ca1 interacts
with PIN1, unlike the muscle-speciﬁc MEF2Ca2 isoform,
devoid of the Ser110 residue (Fig. 2A). Altogether our data
indicate that the MEF2Ca1/PIN1 interaction might play a role
in regulating the proliferative potential of adult myoblasts. To
investigate this, equal numbers of freshly isolated adult SC
were transduced with combinations of lentiviral vectors carry-
ing PIN1 and/or MEF2Ca1 cDNAs, and their proliferation
potential was assayed by evaluating the number of cells after
3 days in culture. We show that PIN1 and MEF2Ca1 synergize
to promote proliferation, with an average 60% increase of cell
number compared to control cells and about 15% increase
versus MEF2Ca1 overexpressing cells (Fig. 3F). These data
indicate that association with PIN1 increases the pro-
proliferative activity of MEF2Ca1 in primary myoblasts. To
reinforce these observations, we used lentiviral vectors encod-
ing MEF2Ca1 mutated in the PIN1 binding sites located in the
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a1 exon (Ser98/110) and in the C-terminus (Ser254 and
Ser388) [24] (SA mutant) and we evaluated the proliferation
and differentiation potential of transduced SC. We found that
the SA mutant is not able to efﬁciently stimulate myoblasts
expansion (Fig. 3G) but retains the ability to promote their
differentiation, expressed as in increase of the percentage of
MGN1 (50%) and TROPONIN T1 (TNT1) (60%) cells (Fig.
3G). Thus, phosphorylation of the PIN1 binding sites
Figure 3.
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represents a switch to turn-on and turn-off alternatively the
pro-proliferative or the pro-differentiative activities of
MEF2Ca1 in cultured adult myoblasts.
Phosphorylation of the a1 Domain in Muscle
Regeneration
We aimed to conﬁrm the relevance of MEF2Ca1 phosphoryla-
tion in SC function in vivo during muscle regeneration. We
ﬁrst validated that this regulatory mechanism is active during
skeletal muscle regeneration upon cardiotoxin (CTX)-induced
injury. Western blot analysis showed that the expression level
of the a1 domain increased in regenerating muscle at 2 days
post-injury (p.i.) and, although it gradually decreased, it
remained expressed throughout the course of regeneration
(Fig. 4A, left and middle panels), together with a remarkable
level of phosphorylation at Ser98/110 at 2 and 5 days p.i., a
time frame concomitant with proliferation of activated SC
(Fig. 4A, right panel). Next we investigated the cellular source
of MEF2C protein by immunoﬂuorescence analysis on cryosec-
tions of regenerating TA muscles at 5 days p.i.: MEF2C protein
is expressed in 100% of centrally located nuclei of newly
formed myoﬁbers and in 30% of mononucleated interstitial
cells (Fig. 4B). In summary our results indicate that the a1
domain is expressed throughout muscle regeneration and is
subjected to a dynamic phosphorylation on Ser98/110, sug-
gesting multiple roles played by MEF2Ca1 in vivo.
Effects of MEF2C Splice Variants Overexpression in
Adult Muscle
To investigate the role of MEF2Ca1/a2 splice variants and of
MEF2Ca1 phosphorylation in SC function in vivo, we performed
a muscle regeneration assay. Due to the high functional redun-
dancy of MEF2 proteins [7], we decided to adopt a gain of func-
tion strategy. TA muscles were subjected to a single CTX injury
and 2 days later they were injected with lentiviruses encoding
the MEF2Ca splice variants and the mutant MEF2Ca1 protein
or the RFP cassette alone. Muscles were analyzed 5 or 15 days
later (as schematized in Supporting Information Fig. 3A). Infec-
tion efﬁciency was >60%-70% for all vectors (Supporting Infor-
mation Fig. 3B) and qRT-PCR analysis conﬁrmed the ectopic
expression of transcripts encoding RFP and MEF2C (Supporting
Information Fig. 3C). Immunoﬂuorescence analysis conﬁrmed
that MEF2C protein is expressed and phosphorylated on Ser98
in activated, DESMIN-positive SC (Supporting Information Fig.
3D). Examination of serial sections of muscles overexpressing
MEF2C proteins revealed an increase in the overall size
throughout the body of the muscle that is particularly pro-
nounced with the 2SA mutant at 15 days p.i. (Fig. 5A). Evalua-
tion of the cross-sectional areas (CSA) of regenerated muscles
showed the presence of a number of hypertrophic myoﬁbers, in
muscles that overexpress all MEF2C proteins, in comparison to
control injected muscles (Fig. 5B). However, the hypertrophic
effect is particularly pronounced upon ectopic expression of the
non-phosphorylatable 2SA mutant, already at an early stage of
regeneration (5 days p.i.). The upper panels of Figures 5B show
the frequency distribution of myoﬁber CSA in the transduced
regenerating muscles. Table C shows the mode and median val-
ues inferred from the histogram and the calculated shifts of CSA
versus the EV control injected muscles. The modal values at 15
days reﬂect the left-shift (880 lm2) with MEF2Ca1 wild type
and the right shift (1440 lm2) with MEF2Ca2 and the non-phos-
phorylatable 2SA mutant, in comparison to control regenerating
muscle, where the majority of ﬁbers were 1280 lm2 in size.
Similarly, we found that the median cross-sectional area of myo-
ﬁbers in muscles overexpressing MEF2Ca2 and 2SA were respec-
tively 1536 lm2 and 1684,53 lm2 versus 1348 lm2 for the
control muscles and 1314,81 lm2 for muscles that overexpress
the wild type protein. The hypertrophic effect of the 2SA mutant
was already evident at the very early stages of muscle regenera-
tion as indicated by the observation that the median CSA of
myoﬁbers was higher (660 lm2) than those of the other sam-
ples, with a shift of 1202,88 lm2, the shift is more evident at
later stages of regeneration (1336,51 lm2). At the 5-day time
point regenerating muscle that overexpress MEF2Ca2 is instead
characterized by a high proportion of smaller newly regenerating
myoﬁbers, with a shift of 280 lm2 and 297,64 lm2 of the
mode and median CSA, probably due to the ability of this splice
variant to promote myotube formation [16].
Exclusively in the case of muscles overexpressing MEF2Ca1,
at 15 days p.i., we observed the coexistence of hypertrophic
ﬁbers (>2400 lm2, 9% of totally counted myoﬁbers) with
small, regenerating ones (<200 lm2) suggesting that, in addi-
tion to the hypertrophic effect, a regenerative process persists
at a stage in which this process has normally ended. This
observation suggest that MEF2Ca1 might stimulate SC prolifer-
ation also in vivo. To address this issue, we quantiﬁed the num-
ber of mononucleated interstitial cells expressing Ki67, a
marker of proliferation, in transduced adult muscles 5 days p.i.
In agreement with the in vitro data, we found that the per-
centage of Ki671 nuclei was increased in MEF2Ca1 (6.5%)
compared to MEF2Ca2 overexpressing (5.38%) and control
muscles (4.8%), whereas ectopic expression of the 2SA mutant
Figure 3. PIN1/MEF2Ca1 interaction in primary myoblasts. (A): Expression level of Pin1 in quiescent (Q), proliferating (P) or differenti-
ating (D) SC. Negative controls: 2RT, 2RNA, PCR reaction mix. Rplp0 was used as a control of RNA quantities. Similar results were
obtained from two sets of samples. (B): Single myoﬁbers were cultured for 48 hours and immunolocalized for PIN1 and MYOD. Bar, 50
lm (C, D): Bimolecular Fluorescence Complementation (BiFC) assay. Myoblasts were transfected with FLAG-YN and HA-PIN1-YC negative
controls (panels i and iv), FLAG-JUN-YN and HA-FOS-YC positive controls (panels ii and v) and FLAG- MEF2Ca1-YN and HA-PIN1-YC (panels
iii and vi). Cells were stained with anti-FLAG (red), anti-HA (blue) or anti-MYOD antibodies and DAPI. The ﬂuorescence of the YFP (green
stain) results from the bimolecular complementation assay. Scale bar, 50 lm. (E): COS-1 cells were cotransfected with HA-tagged PIN1
and FLAG-tagged MEF2C vectors. CoIP was performed with anti-FLAG antibody and immunoblotted for FLAG or HA tags. As shown in
the representative immunoblot, HA-PIN1 is coimmunoprecipitated exclusively with the wild type MEF2Ca1 isoform. These ﬁndings were
replicated over three independent experiments. (F): Myoblasts were transduced with the indicated combinations of lentiviruses. 48 hours
later, DAPI-stained nuclei were counted. Three independent experiments were carried out for each measurement. Error bars5 standard
deviations. ***, p< 0.001, *, p< 0.05. (G): Myoblasts were transduced with lentiviral vectors encoding MEF2Ca1 mutated on the PIN1
binding sites (MEF2C SA), 72 hours later cells were immunostained for MYOGENIN or TROPONIN T (TnT). Three independent experiments
were carried out for each measurement. Error bars represent SEM. Abbreviations: CoIP, coimmunoprecipitation; MEF2C, myocyte
enhancer factor 2C; 2RT, nonreverse-transcribed RNA; 2RNA, reverse transcription mixture; SC, satellite cells TnT, troponin T.
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correlates with an earlier reduction of proliferating interstitial
cells (2.5%) (Fig. 5D). Overall our ﬁndings indicate that both
MEF2Ca1 and MEF2Ca2 splice variants promote muscle regen-
eration and hypertrophy in adult muscles. Furthermore, we
present evidence indicating a bimodal activity of MEF2Ca1 for
which the level of phosphorylation of the PIN1 binding sites
tips the balance toward its ability to promote cell proliferation,
differentiation and muscle growth.
Targets of Overexpressed MEF2C Splice Variants in
Adult Muscle
As MEF2C modulates alternatively muscle- and proliferation-
related genes in a splice variant- and phospho-dependent
manner in cultured myoblasts, we tested whether these regu-
latory mechanisms operate also in vivo. Indeed, qPCR analysis
of RNA extracted from regenerated muscles (15 d.p.i.) showed
that MEF2Ca1 overexpression promotes the expression of the
immediate early gene Plk2 in adult muscle more efﬁciently
than the 2SA mutant or the MEF2Ca2 splice variant, which in
contrast are stronger activators of the muscle-speciﬁc gene
TnnC1 (Fig. 6A). In addition, we observed that both the
MEF2Ca2 isoform and the 2SA mutant are powerful activators
of the expression of insulin like growth factor 1 and 2 (Igf1
and Igf2), two stimulators of myogenesis by activating progen-
itor cell proliferation, terminal differentiation and muscle
growth (Fig. 6B). In line with these results, we observed an
increase in the levels of MYOD and of P38, an inducer of ter-
minal differentiation and of MHC, a myogenic marker, in
muscles that overexpress the non-phosphorylatable MEF2Ca1
mutant and MEF2Ca2 (Fig. 6C). These results suggest that,
analogously to what observed in cultured SC, MEF2Ca1 con-
trols distinct sets of target genes associated with early (myo-
blast proliferation) or late (terminal differentiation) stages of
muscle regeneration in vivo through a Ser98/110-
phosphorylation switch. Furthermore, we found that solely
MEF2Ca2 is able to potently activate the expression of the
cyclin-dependent protein kinases (CDK) inhibitor Cdkn1a (p21)
gene, a MEF2 target gene required for cell cycle withdrawal
of skeletal myoblasts, in accordance with its predominant
myogenic role [16, 35–37].
Next we investigated the pathway underlying the observed
MEF2C-dependent muscle hypertrophy, focusing on the IGF-1 sig-
naling cascade, a major regulator of skeletal muscle mass through
the PI3K/AKT pathway [38, 39]. We, therefore, checked the activa-
tion of AKT/mTOR signaling in regenerating adult muscles overex-
pressing MEF2C proteins and we found that total protein levels
of AKT1, mTOR and the ribosomal protein p70S6K S6 kinase
(S6K) as well as the phosphorylation level of AKT were upregu-
lated upon overexpression of MEF2Ca2 and the 2SA mutant
compared to the wild type MEF2Ca1 protein and the control
samples (Fig. 6D). Noticeably, we observed that only the non-
phosphorylatable 2SA mutant has the ability to increase the lev-
els of phosphorylated S6K, a key step for the activation of protein
synthesis [40]. We also evaluated the myonuclear number in the
same samples by determining the number of nuclei within the
dystrophin-stained sarcolemma and we observed an increase in
myonuclear number in muscles overexpressing MEF2Ca2 (50%)
and the 2SA mutant protein (60%) (Fig. 6E). These data indicate
that MEF2Ca1-dependent muscle hypertrophy is the result of
both protein synthesis and myonuclear fusion and that phosphor-
ylation of Ser98/110 negatively controls these functions.
DISCUSSION
Our major ﬁnding is that MEF2Ca1, a MEF2C splice variant, is a
strong stimulator of skeletal muscle hypertrophic growth, an
effect that depends on two mechanisms, including the activation
Figure 4. MEF2Ca1 is expressed during muscle regeneration and is dynamically phosphorylated on Ser98 and Ser110. (A): Left: West-
ern blot analysis of protein lysates from murine injured (CTX) TA muscles analyzed at 2, 5, and 15 days postinjury with MEF2Ca1. The
controlateral TA muscles were used as control (CTRL). Middle: densitometric analysis of the immunoblot experiment for MEF2Ca1
expression. Each time point, after normalization versus VINCULIN, was compared with the correspondent baseline level in the controlat-
eral leg considered as 1. Right: representative Western Blot analysis of protein lysates from injured TA muscles at 2, 5, and 15 days
postinjury with pSer98 and pSer110 antibodies. The controlateral TA muscles were used as control tissues. For all analysis, VINCULIN
was used as control of the quantity of proteins. (B): Cryosections of regenerating TA muscle 5 d.p.i.; nuclei were stained with DAPI,
MEF2C protein is revealed by anti-MEF2C antibody and localizes in central nuclei (white arrowhead) and in mononucleated interstitial
cells (red arrowhead). Scale bars are 50 lm. Abbreviations: CTX, cardiotoxin; CTRL, control tissues; MEF2C, myocyte enhancer factor 2C.
BARUFFALDI, MONTARRAS, BASILE ET AL. 9
www.StemCells.com VC 2016 The Authors STEM CELLS published by Wiley Periodicals, Inc. on behalf of AlphaMed Press
Figure 5. Overexpression of both MEF2Ca1 and MEF2Ca2 splice variants stimulates muscle regeneration and hypertrophy. (A): Representa-
tive anatomical sections of TA muscles transduced with lentiviral vectors encoding the indicated proteins removed from mice at 15 days after
cardiotoxin injection. Bar: 50 lm. (B): Top: histograms showing the frequency distributions of myoﬁber cross-sectional areas in regenerating
TA muscles transduced with EV or lentiviruses bearing the coding sequences of MEF2Ca1 and MEF2Ca2 or MEF2Ca1 mutated on Ser98 and
Ser110 (2SA) 5 or 15 days p.i. MEF2Ca2- and 2SA-dependent hyperthrophy are indicated by the displacement of the mode from 1280 lm2
in the control group to 1440 lm2. Bottom: representative images of regenerating TA muscle sections immunostained for LAMININ (green).
(C): Tables reporting Mode, Median and shifts obtained from the histograms in B and C. (D): Double immunostaining for KI67 (green) and
DYSTROPHIN (red) and nuclear staining with DAPI (blue) in muscle sections from TA regenerating muscles transduced with EV or MEF2Ca1,
MEF2Ca2 or the 2SA mutant at 5 days p.i. Scale bar, 50lm. On the right are reported the relative percentages of total KI67-positive nuclei in
regenerating TA muscles. Data are mean6 SEM. Abbreviations: EV, empty lentivirus; MEF2C, myocyte enhancer factor 2C.
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Figure 6. MEF2C-dependent expression of proliferation-, differentiation- and growth- associated genes is regulated by alternative inclu-
sion of a1/a2 exons in Mef2c transcripts and by Ser98/110 phosphorylation. The mRNA and protein lysates were obtained from 15
d.p.i. regenerating TA muscles transduced with the indicated lentiviruses and analyzed as described below. (A, B): Plk2, TnnC1, Igf1, Igf2
mRNA expression levels were analyzed by qPCR. Data are expressed as fold induction relative to control muscle transduced with the EV.
At least three independent experiments with duplicate samples were carried out for each measurement. Error bars represent SEM. *,
p< 0.05, **, p< 0.01. (C): Representative Western blot analysis of protein lysates from transduced regenerating muscles with MyHC,
P38, MYOD, and P21 antibodies. (D): Representative Western blot analysis of protein lysates from transduced regenerating muscles
with, AKT1 and 70S6K protein, pAKT on Thr308 and Ser473, mTOR, S6K, and pS6K antibodies. Red Ponceau staining was used as a load-
ing control in C and D. (E): The number of DAPI-stained nuclei within dystrophin-positive sarcolemma were counted in transduced
regenerating muscles, they are expressed per 100 myoﬁbers. Data are mean6 SEM. (F): A model depicting the potential roles played by
MEF2C proteins in adult myogenesis. Phosphorylated MEF2Ca1 promotes satellite cells-derived myoblasts (red cells) proliferation via
upregulating, directly or not, the immediate early genes Plk2 and JunB. Subsequent increase of MEF2Ca2 level drives cell cycle exit, ter-
minal differentiation and myoblast fusion to give newly formed myoﬁbers, by inducing the expression of the CDK inhibitor P21 as well
as P38 and MyoD. Dephosphorylated MEF2Ca1 contributes to the activation of muscle genes in nascent myoﬁbers and it promotes
myoﬁber growth by activating the anabolic AKT/mTOR/S6K pathway. Abbreviations: EV, empty lentivirus; MEF2C, myocyte enhancer fac-
tor 2C; MyHC, myosin heavy chain; pAKT, phospho-AKT; S6K, ribosomal S6Kinase; pS6K, S6K phosphorylated on Thr389.
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of the anabolic AKT/mTOR pathway and its downstream target
pS6K and the addition of new myonuclei via the proliferation
and further fusion of SC-derived myoblasts to the adult myoﬁber.
These different activities are alternatively switched-on by a
dynamic phosphorylation of Ser98 and Ser110, two phosphoac-
ceptor sites encoded by the alternative a1 exon, their phosphory-
lation is paramount in the control of the pro-proliferative
function, given that substitution of these two phosphoacceptor
sites with non-phosphorylatable Alanine residues represses the
pro-proliferative activity and at the same time enhances the pro-
myogenic and hypertrophic abilities of MEF2C. Previous studies
have implicated MEF2 proteins in the control of adult skeletal
muscle regeneration, where they activate the differentiation gene
expression program [7, 8]. In this study we present evidence to
suggest that MEF2C, in addition to the pro-differentiating func-
tion, mainly due to the MEF2Ca2 isoform, also promotes expan-
sion of primary myoblasts, an activity exhibited by the MEF2Ca1
protein in a phosphorylation-dependent manner. On the basis of
our results, we hypothesize that the pro-proliferative activity of
MEF2Ca1 on SC is related to its ability to direct the expression
of Immediate Early Genes, including, JunB, Plk2, which are to be
added to other cycle-related genes that are regulated by MEF2
proteins in muscle [17, 41] and nonmuscle cells [42, 43].
The observed MEF2Ca1-dependent upregulation of JunB is in
line with the results of ChIP analyses performed by the Encyclope-
dia of DNA Elements (ENCODE) consortium in human cells, demon-
strating that MEF2 binds to regions upstream of the JunB gene,
suggesting a direct role of MEF2C in regulating this gene.We iden-
tiﬁed a putative MRE in the promoter region of the JunB gene,
near one conserved CCAATelements, however, in our experimental
conditions, we have not detected a recruitment of MEF2 to the
identiﬁed MRE in front of an efﬁcient binding of the NFY transcrip-
tion factor to its binding site localized in the same region. This data
may then indicate an indirect role of MEF2Ca1 in regulating the
expression of JunB, potentially through other transcription factors.
Plk2 transcripts present a broad tissue distribution and have been
also detected in mouse SC [44]. Our ﬁndings also show that MEF2
proteins directly bind to the putative MRE located in the upstream
region from the transcription sites of Plk2 suggesting that
MEF2Ca1 might actively regulate Plk2 transcription by binding to
an active enhancer.
One process contributing to the pro-proliferative function of
MEF2C in primary myoblasts is the phospho-dependent interaction
with PIN1. In this study we show that PIN1 and MEF2C physically
interact in primary myoblasts and we found not only that PIN1
inhibits myogenic differentiation [24] but also that this interaction
synergistically stimulates their expansion. The use of phospho-
speciﬁc antibodies allowed us to follow the in vivo kinetics of phos-
phorylation of the PIN1 binding sites in the a1 domain: we
observed a strong phosphorylation at Ser98/110 within ﬁve days
after injury, when the regeneration response is at its highest. Later
on, during remodeling of regenerated muscle we found mainte-
nance of MEF2Ca1 expression but we did not detect phosphoryla-
tion at the PIN1 binding sites, suggesting an important role for the
dephosphorylated protein in late phases of adult myogenesis. Our
in vivo studies revealed that ectopic expression of the non-phos-
phorylatable MEF2Ca1 mutant protein induces the expression of
myogenic markers and of P38, whose activity is important for early
phases of myoblast differentiation [45–49] and myocyte fusion
[50]. However, the pro-differentiative activity of the 2SA mutant is
less pronounced than that exerted by MEF2Ca2, which instead
potently stimulates the expression of the CDK inhibitor p21 gene, a
key event for cell cycle exit and myogenic terminal differentiation.
Conversely we observed that the 2SA mutant robustly promotes a
notable increase of the cross-sectional area of myoﬁbers that cor-
relates with the activation of the AKT/mTOR anabolic pathway and
the phosphorylation of the downstream target S6K [40, 51, 52]
and the concomitant increase in the number of myonuclei. Alto-
gether our data suggest a model whereby MEF2C protein variants
promote different stages of myogenesis, ranging from SC prolifera-
tion, terminal differentiation and myoﬁber growth. MEF2Ca1 stim-
ulates muscle growth through two mechanisms, by controlling ﬁrst
SC proliferation when phosphorylated on the PIN1 binding sites,
subsequently, upon dephosphorylation it stimulates myonuclear
accretion and protein synthesis through activation of the mTOR/
S6K pathway (Fig. 6F). In support for this model, fully regenerated
muscles overexpressing MEF2Ca1 are characterized by the coexis-
tence of hypertrophic as well as small newly formed myoﬁbers and
an increase of Ki67-positive cells and Plk2 expression, reﬂecting the
pleiotropic function played by this protein. Given our data, dynam-
ic phosphorylation of Ser98/110 plays a key role in adult myogene-
sis. Both Ser residues are predicted to be dynamically
phosphorylated by proline-directed protein kinases, including CDKs
and mitogen-activated protein kinases (MAPKs), a prediction sup-
ported by our ﬁnding that CDK6/Cyclin D1 phosphorylates MEF2C
at Ser110 in vitro [17] and treatment of cultured cells with CDK6
inhibitors reduces MEF2C phosphorylation. Experiments directed
toward the identiﬁcation of these kinases are the matter of ongo-
ing work. Although MEF2C has been already implicated in activa-
tion of genes that promote cardiac hypertrophy in response to
IGF1 signaling, this is the ﬁrst report of its implication in skeletal
muscle hypertrophy [53–55]. We hypothesize that MEF2C indirect-
ly activates the AKT/mTOR pathway by inducing an up-regulation
of Igf1 and Igf2 gene expression. ChIP analyses performed by the
ENCODE consortium demonstrate that MEF2 is bound to MEF2
sites located in the promoter as well in an upstream region of the
Igf1 gene, suggesting a direct role of MEF2C in promoting the
expression of this gene. Interestingly previous studies indicate that
forced expression of IGF-I can induce Mef2c gene expression in
muscle cells [56]. Our observations of a MEF2C-dependent induc-
tion of Igf1 gene expression suggest a positive-feedback loop
underlying muscle growth [56].
CONCLUSION
In general, our data demonstrate that MEF2C promotes mus-
cle regeneration and growth at two cellular levels: by means
of activating SC proliferation and differentiation to provide
myonuclei to growing myoﬁbers and through promotion of
the IGF1/AKT anabolic signaling pathway in differentiated
myoﬁbers to increase muscle mass. The timely coordination of
these activities in adult myogenesis is ensured by a molecular
mechanism in which alternative splicing and phosphorylation
ﬁnely regulate the activity of MEF2C. Our data supply prelimi-
nary evidence that modulating MEF2Ca1 function might be a
valuable therapeutic strategy for muscle wasting therapies.
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